Search

Issue
Title
Authors
Insulin resistance and its role in the pathogenesis of pre-diabetes development in obese adolescents
Min'kova N.B., Latyshev O.I., Okminyan G.F., Kiseleva E.V., Romaikina D.S., Samsonova L.N.
Dyslipidemia. Barriers on the way of the patient to the implementation of medical recommendations
Sumarokov A.B.
Dyslipidemia and atherosclerosis in type 2 diabetes mellitus patients. Statin therapy characteristics and comparative analysis: endocrinologist’s point of view
Demidova T.Y., Susareva O.V.
Vybor antigipertenzivnogo preparata‌‌ u bol'nogo arterial'noy gipertoniey i patologiey pecheni
Lazebnik L.B., Komissarenko I.A., Mikheeva O.M.
Atorvastatin v lechenii bol'nykh sakharnym diabetom 2-go tipa (k 30-letiyu otkrytiya statinov)
Galyavich A.S.
Tactics of management of patients with cardiovascular diseases. Roundtable report
Konradi A.O., Baranova E.I., Gurevich V.S., Zvartau N.E., Konstantinov V.O., Nifontov E.M., Obrezan A.G., Panov A.V., Sitnikova M.Y.
Clinical studies of rosuvastatin from the GALAXY project in the context of the new EAS/ESC-2016 recommendations on dyslipidemia Part 1
Susekov A.V.
Terapiya arterial'noy gipertenzii u bol'nykhs narusheniem uglevodnogo i lipidnogo obmena, s androgennym defitsitom
Martynov A.I., Akatova E.V., Urlaeva I.V., Nikolin O.P.
Obosnovanie i effektivnost' kombinirovannoy antigipertenzivnoy i gipolipidemicheskoy terapii u patsientov s arterial'noy gipertoniey
Kobalava Z.D., Tolkacheva V.V.
Possibilities of combination lipid-lowering therapy in a patient with very high cardiovascular risk (dinical case)
Sedykh D.Y., Fedorova N.V., Kashtalap V.V.
New opportunities to treat patients with high cardiovascular risk
Baryshnikova G.A., Chorbinskaya S.A.
Primenenie fiksirovannoy kombinatsii antigipertenzivnykh preparatov u zhenshchin s arterial'noy gipertoniey
Stryuk R.I.
Gipolipidemicheskaya terapiya metabolicheskogo sindroma
Chazova I.E., Mychka V.B.
Statins in certain patient populations: scientific evidence and algorithms for practicing physicians
Susekov A.V.
Non-alcoholic fatty liver disease, hyperlipidemia and cardiovascular risks
Shirokova E.N.
Beremennost' i tri osnovnye problemy sovremennykh zhenshchin:ozhirenie, diabet i arterial'naya gipertenziya (v pomoshch' praktikuyushchemu vrachu)
Chukhareva N.A., Runikhina N.K., Esayan R.M., Klimenchenko N.I.
Gipolipidemicheskaya terapiya i reoferez pri dislipoproteidemiyakh
Konovalov G.A., Zvezdkin P.V., Khayutina T.L., Filonenko I.V., Akopyan V.S., Karneeva O.V., Doroshchenko A.D., Kurganskaya T.S.
Goals and possibilities of combined hypolipidemic therapy of cerebrovascular diseases associated with dyslipidemia
Sabirov I.S., Murkamilov I.T., Fomin V.V., Yusupov F.A.
Iatrogenic risk factors and correction of dyslipidemia after liver transplantation
Kosmacheva E.D., Babich A.E.
Kardial'nye yatrogenii pri primenenii peroral'nykh sakharosnizhayushchikh sredstv
Kompaniets O.G.
Lechenie dislipidemii u bol'nykh sakharnym diabetom tipa 2
Kozlov S.G.
REVIEW COMBINED LIPID-LOWERING THERAPY IN EUROPEAN SOCIETY OF CARDIOLOGY AND EUROPEAN ATHEROSCLEROSIS SOCIETY (ESC/EAS) 2019 GUIDELINES: PLACE OF EZETEMIBE
Gurevich V.S.
Approaches to the choice of a statin to treat patients on an outpatient basis
Ostroumova O.D., Dudaev V.A., Schukina G.N.
Metabolicheskiy sindrom kak problema polimorbidnosti
Komissarenko I.A.
Cardiovascular disorders, quality of life, and compliance in the structure of neural network prognostic model of complications development in liver transplant recipients
Kosmacheva E.D., Babich A.E., Khalafian A.A., Akin'shina V.A.
POSSIBILITIES OF RESIDUAL DYSLIPIDEMIA CORRECTION IN PATIENTS WITH MULTIFOCAL ATHEROSCLEROSIS, WHO ARE RECEIVING OPTIMAL STATIN THERAPY
Bogdanov A.R., Pyko M.E., Pyko A.A.
Mnogofaktornyy podkhod k snizheniyu serdechno-sosudistogo riska: vozmozhnosti kombinirovannoy terapii amlodipinom i atorvastatinom
Protasov K.V.
Dislipidemiya kak faktor riska razvitiyaserdechno-sosudistykh zabolevaniy i oslozhneniy
Evdokimova A.G.
Pleiotropic effects of ursodeoxycholic acid in non-alcoholic fatty liver disease and metabolic syndrome
Pirogova I.Y., Yakovleva S.V., Neuimina T.V., Sinitsyn S.P., Chulkov V.S.
WHICH ASPECTS ARE THE MOST SIGNIFICANT IN RUSSIAN AND EUROPEAN GUIDELINES? INTERVIEW
Metabolicheskiy sindrom v praktike pediatra i vracha obshchey praktiki
Zakharova I.N., Zvenigorodskaya L.A., Vasil'eva S.V.
Terapiya narusheniy lipidnogo obmena.Chast' II*
Kukharchuk V.V.
1 - 32 of 32 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies